AlphaTON Capital (ATON) | 1991-1999 | 2,333,235.21% |
Marker Therapeutics (MRKR) | 1991-1999 | 1,428,471.43% |
Amgen (AMGN) | 1991-1999 | 2,225.01% |
Incyte (INCY) | 1991-1999 | 1,500% |
Biogen (BIIB) | 1991-1999 | 991.67% |
Alkermes (ALKS) | 1991-1999 | 379.27% |
BioCryst Pharmaceuticals (BCRX) | 1991-1999 | 353.85% |
ImmuCell (ICCC) | 1991-1999 | 322.22% |
Vertex Pharmaceuticals (VRTX) | 1991-1999 | 283.56% |
United Therapeutics (UTHR) | 1991-1999 | 240.74% |
Compass Therapeutics (CMPX) | 1991-1999 | 236.84% |
Gilead Sciences (GILD) | 1991-1999 | 213.69% |
GeoVax Labs (GOVX) | 1991-1999 | 183.58% |
Imunon (IMNN) | 1991-1999 | 141.03% |
Vera Therapeutics (VERA) | 1991-1999 | 140.87% |
Lineage Cell Therapeutics (LCTX) | 1991-1999 | 124.21% |
Myriad Genetics (MYGN) | 1991-1999 | 113.95% |
Anika Therapeutics (ANIK) | 1991-1999 | 101.79% |
Neurocrine Biosciences (NBIX) | 1991-1999 | 98% |
Theriva Biologics (TOVX) | 1991-1999 | 97.53% |
Opko Health (OPK) | 1991-1999 | 66.67% |
Novavax (NVAX) | 1991-1999 | 66.67% |
Geron (GERN) | 1991-1999 | 62.9% |
Heron Therapeuti (HRTX) | 1991-1999 | 61.76% |
Kazia Therapeutics Ltd ADR (KZIA) | 1991-1999 | 42.86% |
